Human Genome Epidemiology Literature Finder
Cancer
Records 1 - 30 (of 3589 Records) |
Query Trace: Ovarian[original query] |
---|
Integrative multi-omics analyses to identify the genetic and functional mechanisms underlying ovarian cancer risk regions. American journal of human genetics 2024 5 . Eileen O Dareng, Simon G Coetzee, Jonathan P Tyrer, Pei-Chen Peng, Will Rosenow, Stephanie Chen, Brian D Davis, Felipe Segato Dezem, Ji-Heui Seo, Robbin Nameki, Alberto L Reyes, Katja K H Aben, Hoda Anton-Culver, Natalia N Antonenkova, Gerasimos Aravantinos, Elisa V Bandera, Laura E Beane Freeman, Matthias W Beckmann, Alicia Beeghly-Fadiel, Javier Benitez, Marcus Q Bernardini, Line Bjorge, Amanda Black, Natalia V Bogdanova, Kelly L Bolton, James D Brenton, Agnieszka Budzilowska, Ralf Butzow, Hui Cai, Ian Campbell, Rikki Cannioto, Jenny Chang-Claude, Stephen J Chanock, Kexin Chen, Georgia Chenevix-Trench, , Yoke-Eng Chiew, Linda S Cook, Anna DeFazio, Joe Dennis, Jennifer A Doherty, Thilo Dörk, Andreas du Bois, Matthias Dürst, Diana M Eccles, Gabrielle Ene, Peter A Fasching, James M Flanagan, Renée T Fortner, Florentia Fostira, Aleksandra Gentry-Maharaj, Graham G Giles, Marc T Goodman, Jacek Gronwald, Christopher A Haiman, Niclas Håkansson, Florian Heitz, Michelle A T Hildebrandt, Estrid Høgdall, Claus K Høgdall, Ruea-Yea Huang, Allan Jensen, Michael E Jones, Daehee Kang, Beth Y Karlan, Anthony N Karnezis, Linda E Kelemen, Catherine J Kennedy, Elza K Khusnutdinova, Lambertus A Kiemeney, Susanne K Kjaer, Jolanta Kupryjanczyk, Marilyne Labrie, Diether Lambrechts, Melissa C Larson, Nhu D Le, Jenny Lester, Lian Li, Jan Lubi?ski, Michael Lush, Jeffrey R Marks, Keitaro Matsuo, Taymaa May, John R McLaughlin, Iain A McNeish, Usha Menon, Stacey Missmer, Francesmary Modugno, Melissa Moffitt, Alvaro N Monteiro, Kirsten B Moysich, Steven A Narod, Tu Nguyen-Dumont, Kunle Odunsi, Håkan Olsson, N Charlotte Onland-Moret, Sue K Park, Tanja Pejovic, Jennifer B Permuth, Anna Piskorz, Darya Prokofyeva, Marjorie J Riggan, Harvey A Risch, Cristina Rodríguez-Antona, Mary Anne Rossing, Dale P Sandler, V Wendy Setiawan, Kang Shan, Honglin Song, Melissa C Southey, Helen Steed, Rebecca Sutphen, Anthony J Swerdlow, Soo Hwang Teo, Kathryn L Terry, Pamela J Thompson, Liv Cecilie Vestrheim Thomsen, Linda Titus, Britton Trabert, Ruth Travis, Shelley S Tworoger, Ellen Valen, Els Van Nieuwenhuysen, Digna Velez Edwards, Robert A Vierkant, Penelope M Webb, , Clarice R Weinberg, Rayna Matsuno Weise, Nicolas Wentzensen, Emily White, Stacey J Winham, Alicja Wolk, Yin-Ling Woo, Anna H Wu, Li Yan, Drakoulis Yannoukakos, Nur Zeinomar, Wei Zheng, Argyrios Ziogas, Andrew Berchuck, Ellen L Goode, David G Huntsman, Celeste L Pearce, Susan J Ramus, Thomas A Sellers, , Matthew L Freedman, Kate Lawrenson, Joellen M Schildkraut, Dennis Hazelett, Jasmine T Plummer, Siddhartha Kar, Michelle R Jones, Paul D P Pharoah, Simon A Gayth |
Cis- and trans-eQTL TWASs of breast and ovarian cancer identify more than 100 susceptibility genes in the BCAC and OCAC consortia. American journal of human genetics 2024 5 . S Taylor Head, Felipe Dezem, Andrei Todor, Jingjing Yang, Jasmine Plummer, Simon Gayther, Siddhartha Kar, Joellen Schildkraut, Michael P Epste |
Loss of copy numbers of retrotransposons (HERVK) on chromosome 7p11.2 impacts EGFR (Epidermal Growth Factor Receptor)-induced phenotypes for platinum sensitivity and long-term survival in ovarian cancer-A study from the OVCAD consortium. International journal of cancer 2024 5 . Gesa Fromhage, Eva Obermayr, Natalia Bednarz-Knoll, Toon Van Gorp, Eva Welsch, Stephan Polterauer, Elena Ioana Braicu, Sven Mahner, Jalid Sehouli, Ignace Vergote, Nicole Concin, Stefan Kurtz, Sascha Steinbiss, Antje Torge, Robert Zeillinger, Linn Wölber, Burkhard Bran |
Prognostic factors and the role of primary debulking in operable stage IVB ovarian cancer with supraclavicular lymph node metastasis: a retrospective study in Chinese patients. BMC cancer 2024 5 24 (1): 565. Chenlian Quan, Xiaojun Chen, Hao Wen, Xiaohua Wu, Jin |
Mutation characteristics and molecular evolution of ovarian metastasis from gastric cancer and potential biomarkers for paclitaxel treatment. Nature communications 2024 5 15 (1): 3771. Pengfei Yu, Can Hu, Guangyu Ding, Xiaoliang Shi, Jingli Xu, Yang Cao, Xiangliu Chen, Wei Wu, Qi Xu, Jingquan Fang, Xingmao Huang, Shaohua Yuan, Hui Chen, Zhizheng Wang, Ling Huang, Fei Pang, Yian Du, Xiangdong Che |
Association of glucagon-like peptide-1 receptor agonists with risk of cancers-evidence from a drug target Mendelian randomization and clinical trials. International journal of surgery (London, England) 2024 5 . Yuming Sun, Yongjia Liu, Yating Dian, Furong Zeng, Guangtong Deng, Shaorong L |
Prognostic factors of 87 ovarian yolk sac tumor (OYST) patients and molecular characteristics of persistent and recurrent OYST. Gynecologic oncology 2024 5 187 64-73. Shanhui Liang, Huijuan Ge, Shuling Zhou, Jie Tang, Yanzi Gu, Xiaohua Wu, Jin |
The response of pancreatic acinar cell carcinoma to platinum and olaparib therapy in a germline BRCA2 variant carrier: case report and literature review. Familial cancer 2024 5 . Hiroyuki Matsubayashi, Akiko Todaka, Takahiro Tsushima, Yoshimi Kiyozumi, Rina Harada, Eiko Ishihara, Satomi Higashigawa, Nobuyuki Ohike, Hiroki Sakamoto, Junya Sato, Hirotoshi Ishiwatari, Teichi Sugiura, Katsuhiko Uesa |
Blood Lead Level as Marker of Increased Risk of Ovarian Cancer in BRCA1 Carriers. Nutrients 2024 5 16 (9): . Adam Kilja?czyk, Milena Matuszczak, Wojciech Marciniak, Ró?a Derkacz, Klaudia Stempa, Piotr Baszuk, Marta Bry?kiewicz, Krzysztof Lubi?ski, Cezary Cybulski, Tadeusz D?bniak, Jacek Gronwald, Tomasz Huzarski, Marcin R Lener, Anna Jakubowska, Marek Szwiec, Ma?gorzata Stawicka-Nie?acna, Dariusz Godlewski, Artur Prusaczyk, Andrzej Jasiewicz, Tomasz Kluz, Joanna Tomiczek-Szwiec, Ewa Kilar-Kobierzycka, Monika Sio?ek, Rafa? Wi?niowski, Renata Posmyk, Joanna Jarkiewicz-Tretyn, Ping Sun, Rodney J Scott, Steven A Narod, Jan Lubi?s |
The Role of Glutathione Transferase Omega-Class Variant Alleles in Individual Susceptibility to Ovarian Cancer. International journal of molecular sciences 2024 5 25 (9): . Petar Simic, Vesna Coric, Igor Pljesa, Ana Savic-Radojevic, Nebojsa Zecevic, Jovana Kocic, Tatjana Simic, Vladimir Pazin, Marija Pljesa-Ercegov |
Inter-individual variation in ovarian reserve after gonadotoxic treatment in female childhood cancer survivors - a genome-wide association study: results from PanCareLIFE. Fertility and sterility 2024 5 . M E Madeleine van der Perk, Linda Broer, Yutaka Yasui, Joop S E Laven, Leslie L Robison, Wim J E Tissing, Birgitta Versluys, Dorine Bresters, Gertjan J L Kaspers, Cornelis B Lambalk, Annelies Overbeek, Jacqueline J Loonen, Catharina C M Beerendonk, Julianne Byrne, Claire Berger, Eva Clemens, Eline van Dulmen-den Broeder, Uta Dirksen, Helena J van der Pal, Andrica C H de Vries, Jeanette Falck Winther, Andreas Ranft, Sophie D Fosså, Desiree Grabow, Monica Muraca, Melanie Kaiser, Tomáš Kepák, Jarmila Kruseova, Dalit Modan-Moses, Claudia Spix, Oliver Zolk, Peter Kaatsch, Leontien C M Kremer, Russell J Brooke, Fan Wang, Jessica L Baedke, André G Uitterlinden, Annelies M E Bos, Flora E van Leeuwen, Kirsten K Ness, Melissa M Hudson, Anne-Lotte L F van der Kooi, Marry M van den Heuvel-Eibrink, |
Mutational signature-based identification of DNA repair deficient gastroesophageal adenocarcinomas for therapeutic targeting. NPJ precision oncology 2024 4 8 (1): 87. Aurel Prosz, Pranshu Sahgal, Brandon M Huffman, Zsofia Sztupinszki, Clare X Morris, David Chen, Judit Börcsök, Miklos Diossy, Viktoria Tisza, Sandor Spisak, Pornlada Likasitwatanakul, Orsolya Rusz, Istvan Csabai, Michael Cecchini, Yasmine Baca, Andrew Elliot, Peter Enzinger, Harshabad Singh, Jessalyn Ubellaker, Jean-Bernard Lazaro, James M Cleary, Zoltan Szallasi, Nilay S Set |
Exploring evolutionary trajectories in ovarian cancer patients by longitudinal analysis of ctDNA. Clinical chemistry and laboratory medicine 2024 4 . Oliver Kutz, Stephan Drukewitz, Alexander Krüger, Daniela Aust, Doreen William, Sandra Oster, Evelin Schröck, Gustavo Baretton, Theresa Link, Pauline Wimberger, Jan Dominik Kuhlma |
Long-term oncologic outcomes of unselected triple-negative breast cancer patients according to BRCA1/2 mutations. NPJ precision oncology 2024 4 8 (1): 96. Woong Ki Park, Soo Yeon Chung, You Jin Jung, Changhee Ha, Jong-Won Kim, Seok Jin Nam, Seok Won Kim, Jonghan Yu, Byung Joo Chae, Jeong Eon Lee, Sung-Won Kim, Jai Min Ryu, |
Gray matter volume in women with the BRCA mutation with and without ovarian removal: evidence for increased risk of late-life Alzheimer's disease or dementia. Menopause (New York, N.Y.) 2024 4 . Suzanne T Witt, Alana Brown, Laura Gravelsins, Maria Engström, Elisabet Classon, Nina Lykke, Elisabeth Åvall-Lundqvist, Elvar Theordorsson, Jan Ernerudh, Preben Kjölhede, Gillian Einste |
The Genetic Paradigm of Hereditary Breast and Ovarian Cancer (HBOC) in the Afro-Caribbean Population. Critical reviews in oncogenesis 2024 4 29 (3): 99-112. Danielle Cerbon, Daphanie Taylor, Priscila Barreto-Coelho, Estelamari Rodriguez, Matthew Schlumbrecht, Judith Hurley, Sophia H L Geor |
Olaparib and niraparib as maintenance therapy in patients with newly diagnosed and platinum-sensitive recurrent ovarian cancer: A single-center study in China. Chinese medical journal 2024 4 . Dengfeng Wang, Xunwei Shi, Jiao Pei, Can Zhang, Liping Peng, Jie Zhang, Jing Zheng, Chunrong Peng, Xiaoqiao Huang, Xiaoshi Liu, Hong Liu, Guonan Zha |
Using Portuguese BRCA pathogenic variation as a model to study the impact of human admixture on human health. BMC genomics 2024 4 25 (1): 416. Stephanie Andaluz, Bojin Zhao, Siddharth Sinha, Philip Naderev Panuringan Lagniton, Diogo Alpuim Costa, Xiaofan Ding, Miguel Brito, San Ming Wa |
Evaluation of serum CA125, HE4 and CA724 and the risk of ovarian malignancy algorithm score in the diagnosis of high-grade serous ovarian cancer. European journal of obstetrics, gynecology, and reproductive biology 2024 4 297 170-175. Deyu Hu, Jun Qian, Fenghua Yin, Bing Wei, Jiayu Wang, Huijuan Zhang, Haiou Ya |
Endometrial Cancer in a Family With RAD51D Gene Mutation. International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2024 4 . Brittany Gilmore, Linda Logan, Wendy McKinnon, Elise Everett, Bronwyn H Brya |
Exploring the effect of BRCA1/2 status on chemotherapy-induced hematologic toxicity in patients with ovarian cancer. Cancer chemotherapy and pharmacology 2024 4 . In Hee Lee, Soo Jung Lee, Juhyung Kim, Yoon Hee Lee, Gun Oh Chong, Jong Mi Kim, Juhun Lee, Nan Young Lee, Seo Young Park, Dea Gy Hong, Yee Soo Ch |
Collateral damage of NUDT15 deficiency in cancer provides a cancer pharmacogenetic therapeutic window with thiopurines. bioRxiv : the preprint server for biology 2024 4 . Jacob C Massey, Joseph Magagnoli, S Scott Sutton, Phillip J Buckhaults, Michael D Wya |
Germline mutations in BRCA1 and BRCA2 among Brazilian women with ovarian cancer treated in the Public Health System. BMC cancer 2024 4 24 (1): 499. Caroline de Oliveira Ferreira, Vandré Cabral Gomes Carneiro, Carolline Araujo Mar |
Matrix Metalloproteinase-7 Promoter Site Single Nucleotide Polymorphism (-181A>G) in Epithelial Ovarian Cancer in the Eastern Indian Population. Cureus 2024 4 16 (3): e56417. Anudeep P P, Suchitra Kumari, Saroj Dasmajumdar, Manaswini Mangar |
Dynamics of clonal hematopoiesis under DNA-damaging treatment in patients with ovarian cancer. Leukemia 2024 4 . Christopher Maximilian Arends, Klara Kopp, Raphael Hablesreiter, Natalia Estrada, Friederike Christen, Ute Martha Moll, Robert Zeillinger, Wolfgang Daniel Schmitt, Jalid Sehouli, Hagen Kulbe, Maximilian Fleischmann, Isabelle Ray-Coquard, Alain Zeimet, Francesco Raspagliesi, Claudio Zamagni, Ignace Vergote, Domenica Lorusso, Nicole Concin, Lars Bullinger, Elena Ioana Braicu, Frederik Da |
Randomized Phase II Study of Gemcitabine With or Without ATR Inhibitor Berzosertib in Platinum-Resistant Ovarian Cancer: Final Overall Survival and Biomarker Analyses. JCO precision oncology 2024 4 8 e2300635. Panagiotis A Konstantinopoulos, Su-Chun Cheng, Elizabeth K Lee, Alexandre André B A da Costa, Doga Gulhan, Andrea E Wahner Hendrickson, Bose Kochupurakkal, David L Kolin, Elise C Kohn, Joyce F Liu, Richard T Penson, Elizabeth H Stover, Jennifer Curtis, Hannah Sawyer, Madeline Polak, Dipanjan Chowdhury, Alan D D'Andrea, Anniina Färkkilä, Geoffrey I Shapiro, Ursula A Matulon |
Exome sequencing identifies HELB as a novel susceptibility gene for non-mucinous, non-high-grade-serous epithelial ovarian cancer. medRxiv : the preprint server for health sciences 2024 4 . Ed M Dicks, Jonthan P Tyrer, Suzana Ezquina, Michelle Jones, John Baierl, Pei-Chen Peng, Michael Diaz, Ellen Goode, Stacey J Winham, Thilo Dörk, Toon Van Gorp, Ana De Fazio, David Bowtell, Kunle Odunsi, Kirsten Moysich, Marina Pavanello, Ian Campbell, James D Brenton, Susan J Ramus, Simon A Gayther, Paul D P Pharo |
A Study on the Retrospective Reinterpretation of BRCA1 and BRCA2 Variants. Clinical laboratory 2024 4 70 (4): . Jin Ju Kim, Dong Ja Kim, Eon Jeong Nam, Kyung Eun Song, Ji Yeon Ham, Yu Kyung Kim, Nan Young L |
PRDM1 rs2185379, unlike BRCA1, is not a prognostic marker in patients with advanced ovarian cancer. Cancer biomarkers : section A of Disease markers 2024 4 . Klara Horackova, Michal Vocka, Sarka Lopatova, Petra Zemankova, Zdenek Kleibl, Jana Soukupo |
Case report: Response to everolimus in a patient with platinum resistant, high grade serous ovarian carcinoma with biallelic TSC2 inactivation. Frontiers in oncology 2024 4 14 1357980. Mariko Peterson, David L Kolin, Panagiotis A Konstantinopoul |
- Page last reviewed:Feb 1, 2024
- Page last updated:May 20, 2024
- Content source: